Safety and Efficacy of BRM421 for Dry Eye Syndrome
Status:
Completed
Trial end date:
2017-06-28
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic
Solution to placebo for the treatment of the signs and symptoms of dry eye.